The impact of product information and trials on demand for smokeless tobacco and cigarettes: Evidence from experimental auctions

Preventive Medicine

Volumn 60, Issue , 2014, Pages 3-9

  Rousu, Matthew C ^a   O'Connor, Richard J ^b   Thrasher, James F ^e,f   June, Kristie M ^b   Bansal Travers, Maansi ^b   Pitcavage, James ^c,d  

^a SUSQUEHANNA UNIVERSITY   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

^c GEISINGER HEALTH SYSTEM   (United States)

^d PENNSYLVANIA STATE UNIVERSITY   (United States)

^e UNIVERSITY OF SOUTH CAROLINA   (United States)

^f INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

Author keywords

Communications; Experimental auctions; Information; Smokeless tobacco

Indexed keywords

COMMUNICATIONS; EXPERIMENTAL AUCTIONS; INFORMATION; SMOKELESS TOBACCO;

ADULT; ATTITUDE TO HEALTH; COMPETITIVE BIDDING; FEMALE; HEALTH EDUCATION; HUMANS; MALE; MIDDLE AGED; NEW YORK; OBSERVATION; PENNSYLVANIA; PERSUASIVE COMMUNICATION; PRODUCT LABELING; QUESTIONNAIRES; REGRESSION ANALYSIS; SMOKING; SMOKING CESSATION; SOCIAL CLASS; SOUTH CAROLINA; TOBACCO USE CESSATION PRODUCTS; TOBACCO, SMOKELESS; URBAN POPULATION;

EID: 84893824470     PISSN: 00917435     EISSN: 10960260     Source Type: Journal    
DOI: 10.1016/j.ypmed.2013.11.001     Document Type: Article

References (46)

1. Biener L., McCausland K., Curry L., Cullen J. Prevalence of trial of snus products among adult smokers. Am. J. Public Health 2011, 101:1874-1876. 10.2105/AJPH.2010.200097.
2. Borland R., Cooper J., McNeill A., O'Connor R., Cummings K.M. Trends in beliefs about the harmfulness and use of stop-smoking medications and smokeless tobacco products among cigarettes smokers: findings from the ITC four-country survey. Harm Reduct. J. 2011, 23:8-21. 10.1186/1477-7517-8-21.
3. Centers for Disease Control and Prevention Smoking & tobacco use (Retrieved September 5, 2013). http://www.cdc.gov/tobacco/data_statistics/state_data/state_highlights/2012/map/index.htm.
4. Chang, Jae Bong, Jayson L., Lusk F., Bailey Norwood How closely do hypothetical surveys and laboratory experiments predict field behavior?. American Journal of Agricultural Economics 2009, 91.2:518-534.
5. Critchley J.A., Unal B. Health effects associated with smokeless tobacco: a systematic review. Thorax 2003, 58(5):435-443.
6. Critchley J.A., Unal B. Is smokeless tobacco a risk factor for coronary heart disease? A systematic review of epidemiological studies. Eur. J. Cardiovasc. Preventative Cardiol. 2004, 11:101-112. 10.1097/01.hjr.0000114971.39211.d7.
7. Ding M., Eliashberg J., Huber J., Saini R. Emotional bidders-An analytical and experimental examination of consumers' behavior in a priceline-like reverse auction. Management Science 2005, 51(3):352-364.
8. Ferguson S.G., Gitchell J.G., Shiffman S., Sembower M.A., Rohay J.M., Allen J. Providing accurate safety information may increase a smoker's willingness to use nicotine replacement therapy as part of a quit attempt. Addict. Behav. 2011, 36(7):713-716. (Jul). 10.1016/j.addbeh.2011.02.002.
9. Greene Wiliam H. Econometric Analysis 2000, Prentice Hall, Inc. Fourth Edition.
10. Heavner K.K., Rosenberg Z., Tenorio F., Phillips C.V. Retailers' knowledge of tobacco harm reduction following the introduction of a new brand of smokeless tobacco. Harm Reduct. J. 2010, 7:18. (Jul 29). 10.1186/1477-7517-7-18.
11. Henley S.J., Thun M.J., Connell C., Calle E.E. Two large prospective studies of mortality among men who use snuff or chewing tobacco (United States). Cancer Causes Control 2005, 16:347-358. 10.1007/s10552-004-5519-6.
12. International Agency for Research on Cancer IARC monographs on the evaluation of carcinogenic risks to humans. Smokeless Tobacco and Some Tobacco-specific N-nitrosamines 2007, vol. 89. IARC, Lyon.
13. Kozlowski L.T. Effect of smokeless tobacco product marketing and use on population harm from tobacco use policy perspective for tobacco-risk reduction. Am. J. Preventative Med. 2006, 33(Supplement 6):S379-S386. 10.1016/j.amepre.2007.09.015.
14. Kozlowski L.T., Edwards B.Q. "Not safe" is not enough: smokers have a right to know more than there is no safe tobacco product. Tob. Control. 2005, 14(Suppl. 2):ii3-ii7. (Aug).
15. Levy D.T., Mumford E.A., Cummings K.M., et al. The relative risks of a low-nitrosamine smokeless tobacco product compared with smoking cigarettes: estimates of a panel of experts. Cancer Epidemiol. Biomark. Prev. 2004, 13:2035-2042. (Retrieved from http://cebp.aacrjournals.org/content/13/12/2035.long).
16. Levy D.T., Mumford E.A., Cummings K.M., et al. The potential impact of a low-nitrosamine smokeless tobacco product on cigarette smoking in the United States: estimates of a panel of experts. Addict. Behav. 2006, 31:1190-1200. (Epub 2005). 10.1016/j.addbeh.2005.09.010.
17. List J.A., Gallet C.A. What experimental protocol influence disparities between actual and hypothetical stated values?. Environ. Resour. Econ. 2001, 20(3):241-254. (Retrieved from http://www.rps-chicago.com/papers/33-fulltext.pdf).
18. Lusk J.L., Shogren J.F. Experimental Auctions. Methods and Applications in Economic and Marketing Research 2007, Cambridge University Press, Cambridge, UK.
19. Mankiw Gregory N. Principles of Microeconomics 2011, South-Western Pub.
20. Monchuk D., Rousu M.C., Shogren J., Nonnemaker J., Kosa K. Measuring smokers' preferences for low-nicotine cigarettes: evidence from a field experiment. Nicotine Tob. Res. 2007, 9(1):93-99. (Retrieved from http://www.rti.org/pubs/Smoke_pref_cig.pdf).
21. National Cancer Institute The Role of the Media in Promoting and Preventing Tobacco Use 2008, National Institutes of Health, National Cancer Institute, Wakefield Bethesda, MD. R.M. Davis, E.A. Gilpin, B. Loken, K. Viswanath, A. Melanie (Eds.).
22. O'Connor R.J., McNeill A., Borland R., et al. Smokers' beliefs about the relative safety of other tobacco products: findings from the ITC collaboration. Nicotine Tob. Res. 2007, 9:1033-1042. 10.1080/14622200701591583.
23. O'Connor R.J., Norton K.J., Bansal-Travers M., Mahoney M.C., Cummings K.M., Borland R. US smokers' reactions to a brief trial of oral nicotine products. Harm Reduct. J. 2011, 8(1):1. (Jan 10). 10.1186/1477-7517-8-1.
24. O'Connor R.J., June K.M., Bansal-Travers M., et al. Estimating demand among smokers for alternatives to cigarettes. Working Paper 2012.
25. O'Connor R.J., June K.M., Bansal-Travers M., et al. Estimating demand for alternatives to cigarettes with online purchase tasks. Am J Health Behav. 2014, 38(1):103-113. 10.5993/AJHB.38.1.11.
26. Phillips C.V., Heavner K.K. Smokeless tobacco: the epidemiology and politics of harm. Biomarkers 2009, 14(Suppl. 1):79-84. 10.1080/13547500902965476.
27. Rees V.W., Kreslake J.M., Cummings K.M., et al. Assessing consumer responses to potential reduced exposure tobacco products: a review of tobacco industry and independent research methods. Cancer Epidemiol. Biomark. Prev. 2009, 18(12):3225-3240.
28. Rodu B., Godshall W.T. Tobacco harm reduction: an alternative cessation strategy for inveterate smokers. Harm Reduct. J. 2006, 21:37. 10.1186/1477-7517-3-37.
29. Rogers J.D., Biener L., Clark P.I. Test marketing of new smokeless tobacco products in four U.S. cities. Nicotine Tob. Res. 2010, 12(1):69-72.
30. Rousu M.C., Thrasher J.F. Demand reduction from plain and pictorial cigarette warning labels: evidence from experimental auctions. Appl. Econ. Perspect. Policy 2012, Forthcoming.
31. Rousu M., Huffman W.E., Shogren J.F., Tegene A. Effects and value of verifiable information in a controversial market: evidence from lab auctions of genetically modified food. Econ. Inq. 2007, 45:409-432. 10.1111/j.1465-7295.2007.00017.x.
32. Rousu M., Beach R., Corrigan J. The effects of selling complements and substitutes on consumer willingness to pay: evidence from laboratory experiments. Can. J. Agric. Econ. 2008, 56:179-194. 10.1111/j.1744-7976.2008.00124.x.
33. Rousu M., Nonnemaker J., Farrelly M. The value of countermarketing information to smokers: evidence from field auctions. J. Agric. Appl. Econ. 2011, 43(4):607-620. (Retrieved from http://ageconsearch.umn.edu/bitstream/49219/2/value%20of%20countermarketing%20-%20for%20AAEA%20meetings%204-28.pdf).
34. Royal College of Physicians and Tobacco Advisory Group of the Royal College of Physicians Harm reduction in nicotine addiction: helping people who can't quit. London. Ref Type: Report 2007, (Retreived from http://www.tobaccoprogram.org/pdf/4fc74817-64c5-4105-951e-38239b09c5db.pdf).
35. Sami M., Timberlake D.S., Nelson R., Goettsch B., Ataian N., Libao P., Vassile E. Smokers' perceptions of smokeless tobacco and harm reduction. Journal of Public Health Policy 2012, 33(2):188-201.
36. Schneider N.G., Cortner C., Justice M., et al. Preferences among five nicotine treatments based on information versus sampling. Nicotine Tob. Res. 2008, 10:179-186. 10.1080/14622200701767837.
37. Shogren J.F., Margolis M., Koo C., List J. A random nth-price auction. J. Econ. Behav. Organ. 2001, 46:409-421. (December). 10.1016/S0167-2681(01)00165-2.
38. Stratton K., Shetty P., Wallace R., Bondurant S. Clearing the Smoke: Assessing the Science Base for Tobacco Harm Reduction 2001, National Academies Press, Washington DC.
39. Thrasher J.F., Rousu M.C., Anaya-Ocampo R., Reynales-Shigematsu L.M., Arillo-Santillán E., Hernández-Ávila M. Estimating the impact of graphic warning labels on cigarette packs: the auction method. Addict. Behav. 2007, 32(12):2916-2915. 10.1016/j.addbeh.2007.05.018.
40. Thrasher J.F., Rousu M., Hammond D., Navarro A., Corrigan J.R. Estimating the impact of food and drug administration regulation of cigarette package warning labels and the added impact of plain packaging: evidence from experimental auctions among adult smokers. Health Policy 2011, 102(1):41-48.
41. Timberlake D.S. Are smokers receptive to using smokeless tobacco as a substitute?. Prev. Med. 2009, 49(2-3):229-232. (Aug-Sep). 10.1016/j.ypmed.2009.07.012.
42. Tobacco products scientific advisory committee TPSAC Report on Dissolvable Tobacco Products 2012, 1. Center for Tobacco Products, Food and Drug Administration, Rockville, (Retrieved from http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/TobaccoProductsScientificAdvisoryCommittee/UCM295842.pdf).
43. Tomar S.L., Hatsukami D.K. Perceived risk of harm from cigarettes or smokeless tobacco among U.S. high school seniors. Nicotine Tob. Res. 2007, 9:1191-1196. 10.1080/14622200701648417.
44. Tomar S.L., Fox B.J., Severson H.H. Is smokeless tobacco use an appropriate public health strategy for reducing societal harm from cigarette smoking?. Int. J. Environ. Res. Public Health 2009, 1:10-24.
45. Waxman H. Family smoking prevention and tobacco control act. Congress tU 2009, H.R.1256 (Ed.).
46. Zeller M., Hatsukami D., Strategic Dialogue on Tobacco Harm Reduction Group The strategic dialogue on tobacco harm reduction: a vision and blueprint for action in the US. Tob. Control. 2009, 18:324-332. 10.1136/tc.2008.027318.